The Pharmacological Management of Diabetic Peripheral Neuropathy: A Review of Remittive vs. Palliative Therapy

NACCME

Sponsored by the North American Center for Continuing Medical Education (NACCME)

Target Audience

Vascular Surgeons, Endocrinologists, Podiatrists, Nurses, Primary Care Physicians, Wound Care Specialists, and Diabetic Educators

Learning Objectives

Upon completion of this educational activity, participants should be able to:

Understand the economic and social impact of diabetic peripheral neuropathy
Distinguish between positive and negative symptoms of diabetic peripheral neuropathy
Describe the concept of remittive vs. palliative therapy in the management of diabetic peripheral neuropathy .
Discuss the role of elevated homocysteine levels and diabetic peripheral neuropathy
Describe the potential mechanism of action of a novel pharmacologic agent in the management of symptomatic diabetic peripheral neuropathy

CME Accreditation

MD/DO:This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

CME Accreditation for Podiatrists

NACCME is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. This program is approved for 1 continuing education contact hour.

Nurses Accreditation

ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.

Pharmacists Accreditation

NACCME is accredited by the Accreditation Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. NACCME designates this continuing education activity for 1 contact hour (0.1 CEU) of the Accreditation Council on Pharmaceutical Education. Universal Program Number 276-000-07-011-H01-PA statement of credit will be issued via US Mail within 8 weeks after successful completion of the activity post-test. A passing score of 70% is required for successful completion.

Grant Support

This activity is supported by an educational grant from PamLab.

Participating Faculty

James Larocque, MD
Endocrinology and Diabetes Center
Chesapeake, VA

Financial Disclosure and Conflicts of Interest

All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose to the meeting audience any real or apparent conflicts of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on presentations; they are simply noted here to fully inform participants. Dr. Larocque has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of his presentation. Reviewer: J. Reitano, M.D. has no significant financial relationship.